Blueprint for Better Cancer Immunotherapies
November 26, 2024
November 26, 2024
CAMBRIDGE, Massachusetts, Nov. 26 (TNSres) -- The Massachusetts Institute of Technology issued the following news:
* * *
By examining antigen architectures, MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments.
* * *
By Bendta Schroeder, Koch Institute
Immune checkpoint blockade (ICB) therapies can be very effective against some cancers by helping the immune sys . . .
* * *
By examining antigen architectures, MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments.
* * *
By Bendta Schroeder, Koch Institute
Immune checkpoint blockade (ICB) therapies can be very effective against some cancers by helping the immune sys . . .